Insider Stock Trading History of Hobbs Eamonn P


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Hobbs Eamonn P since year 2005. The trader's CIK number is 1235670. At the time of this reporting, Hobbs Eamonn P is the President and CEO of Antares Pharma Inc . (stock ticker symbol AIS). See this page for all insider trading activities at Antares Pharma Inc .

Note that in the past HOBBS EAMONN P also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Hobbs Eamonn P since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-09-10 ATRS Antares Pharma Inc Buy 9,000 2.20 19,800
2013-06-25 ATRS Antares Pharma Inc Sale 23,500 4.19 98,465
2012-06-01 DCTH Delcath Systems Inc Buy 7,000 1.52 10,612
2009-12-15 AIS Antares Pharma Inc Buy 20,000 1.07 21,400
2009-11-18 DCTH Delcath Systems Inc Buy 100,000 3.60 360,000
2009-02-13 ANGO Angiodynamics Inc Sale 15,000 12.98 194,775
2008-04-16 ANGO Angiodynamics Inc Buy 2,715 12.97 35,205
2007-03-30 ANGO Angiodynamics Inc Option Ex 8,364 4.35 36,358
2007-01-10 ANGO Angiodynamics Inc Buy 1,000 24.48 24,480
2006-11-01 ANGO Angiodynamics Inc Option Ex 4,082 4.35 17,744
2006-11-01 ANGO Angiodynamics Inc Sale 4,082 21.62 88,265
2006-10-02 ANGO Angiodynamics Inc Sale 15,000 20.73 310,965
2006-10-02 ANGO Angiodynamics Inc Option Ex 15,000 4.35 65,205
2006-09-26 ANGO Angiodynamics Inc Option Ex 15,000 4.35 65,205
2006-09-26 ANGO Angiodynamics Inc Sale 15,000 21.11 316,590
2006-09-11 ANGO Angiodynamics Inc Option Ex 10,000 4.35 43,470
2006-08-11 ANGO Angiodynamics Inc Option Ex 10,000 4.35 43,470
2006-08-11 ANGO Angiodynamics Inc Option Ex 10,000 4.35 43,470
2006-08-01 ANGO Angiodynamics Inc Option Ex 10,000 4.35 43,470
2006-08-01 ANGO Angiodynamics Inc Sale 10,000 21.94 219,400
2006-07-05 ANGO Angiodynamics Inc Option Ex 20,000 4.35 86,940
2006-07-05 ANGO Angiodynamics Inc Sale 20,000 26.37 527,320
2006-06-01 ANGO Angiodynamics Inc Option Ex 20,000 4.35 86,940
2006-06-01 ANGO Angiodynamics Inc Sale 20,000 27.56 551,140
2006-05-12 ANGO Angiodynamics Inc Option Ex 5,000 4.35 21,735
2006-04-24 ANGO Angiodynamics Inc Sale 4,000 30.15 120,600
2006-05-01 ANGO Angiodynamics Inc Option Ex 30,000 4.35 130,410
2006-05-01 ANGO Angiodynamics Inc Sale 30,000 29.77 893,100
2006-04-24 ANGO Angiodynamics Inc Option Ex 4,000 4.35 17,388
2006-04-20 ANGO Angiodynamics Inc Sale 5,500 30.00 165,000
2006-04-20 ANGO Angiodynamics Inc Option Ex 5,500 4.35 23,908
2006-04-07 ANGO Angiodynamics Inc Option Ex 500 4.35 2,173
2006-04-07 ANGO Angiodynamics Inc Sale 500 30.02 15,010
2006-03-31 ANGO Angiodynamics Inc Option Ex 10,000 4.35 43,470
2006-04-03 ANGO Angiodynamics Inc Option Ex 20,000 4.35 86,940
2006-03-31 ANGO Angiodynamics Inc Sale 10,000 30.00 300,000
2006-04-03 ANGO Angiodynamics Inc Sale 20,000 28.36 567,240
2006-03-14 ANGO Angiodynamics Inc Sale 9,000 25.02 225,180
2006-03-14 ANGO Angiodynamics Inc Option Ex 9,000 4.35 39,123
2006-03-13 ANGO Angiodynamics Inc Option Ex 10,000 4.35 43,470
2006-03-02 ANGO Angiodynamics Inc Option Ex 10,000 4.35 43,470
2006-03-01 ANGO Angiodynamics Inc Option Ex 11,000 4.35 47,817
2006-03-01 ANGO Angiodynamics Inc Sale 11,000 24.88 273,636
2006-02-14 ANGO Angiodynamics Inc Option Ex 9,100 4.35 39,557
2006-02-01 ANGO Angiodynamics Inc Sale 15,000 26.87 403,005
2006-02-01 ANGO Angiodynamics Inc Option Ex 15,000 4.35 65,220
2006-01-06 ANGO Angiodynamics Inc Option Ex 2,000 4.35 8,696
2006-01-06 ANGO Angiodynamics Inc Sale 2,000 26.75 53,500
2006-01-03 ANGO Angiodynamics Inc Option Ex 13,000 4.35 56,524
2006-01-03 ANGO Angiodynamics Inc Sale 13,000 25.20 327,626

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hobbs Eamonn P (President and CEO of Antares Pharma Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.